BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 26, 2000
View Archived Issues
Licensing opportunity from NIH: modified HCV peptide vaccine
Read More
Genentech and Aradigm commence phase II study of CF therapy
Read More
FDA accepts InKine's Diacol NDA for filing
Read More
The Medicines Company acquires bacterial vaginosis treatment from GyneLogix
Read More
Medinox's NO neutralizer blocks sepsis in rat model
Read More
Antisense oligonucleotides designed at Isis for modulating PKC expression
Read More
DuPont scientists prepare new antiplatelet fibrinogen antagonists
Read More
Ontogen achieves milestone in PTPase collaboration with Novo Nordisk
Read More
Lilly designs new series for activating the 5-ht1f receptor
Read More
Anticancer and antimetastatic integrin inhibitors in the pipeline at BioChem Pharma
Read More
Antimalarial benflumetol derivatives with improved activity disclosed by Novartis
Read More
4-Arylpiperidines as 5-HT reuptake inhibitors
Read More
Novel, highly water soluble salt of sildenafil suitable for intranasal administration
Read More
Revised labeling for Propulsid prompted by continuing reports of cardiac adverse events
Read More
Angstrom's A6 receives U.S. patent protection; company preparing to begin phase I trials
Read More
Metabolex acquires Shaman's antidiabetic drug development program
Read More
Advanced cancer stabilized by copper-lowering drug in U-M study
Read More
Biomira initiates next stage of phase II testing of BLP25/liposomal IL-2
Read More
U.S. patent issues for Ribozyme's hepatitis B virus ribozyme
Read More
PADRE technology shows promise as universal vaccine immune stimulant
Read More
Overcoming antibiotic resistance: unusually high bactericidal activity of nisin explained
Read More
Synaptic and Kissei enter genomics research collaboration
Read More
Phase III results disappointing for marimastat in pancreatic cancer
Read More
Scios discusses plans for p38 kinase inhibitors
Read More
IL-9 expression increased in asthma
Read More
EPISTENT diabetic subgroup results: abciximab + stenting associated with better outcome
Read More
Amgen files for regulatory approval of NESP and Kineret during 1999
Read More